Insider Transactions in Q4 2023 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2023
|
Martin Edwards Director |
BUY
Open market or private purchase
|
Direct |
33,736
+18.9%
|
$33,736
$1.84 P/Share
|
|
Nov 06
2023
|
David R Ebsworth Director |
BUY
Open market or private purchase
|
Direct |
160,000
+15.93%
|
$160,000
$1.98 P/Share
|
|
Nov 03
2023
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
58,752
-2.03%
|
$58,752
$1.92 P/Share
|
|
Nov 01
2023
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
196,096
+15.61%
|
-
|
|
Nov 01
2023
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
196,096
-10.64%
|
-
|
|
Nov 01
2023
|
Claire Poll General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
173,904
-8.62%
|
$173,904
$1.74 P/Share
|
|
Nov 01
2023
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
173,136
-5.64%
|
$173,136
$1.74 P/Share
|
|
Nov 01
2023
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
809,008
-4.96%
|
$809,008
$1.74 P/Share
|
|
Nov 01
2023
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
809,008
-4.69%
|
$809,008
$1.74 P/Share
|
|
Oct 20
2023
|
Mark W Hahn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+4.67%
|
-
|
|
Oct 20
2023
|
Claire Poll General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+9.02%
|
-
|
|
Oct 20
2023
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+6.11%
|
-
|
|
Oct 20
2023
|
David Zaccardelli President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+4.44%
|
-
|